CD33 and breast cancer: BC patients had significantly lower percentages of CD14+CD15−CD33+CD11b+HLA-DR− M-MDSCs and significantly greater percentages of CD14−CD15+CD33+CD11b+HLA-DR− PMN-MDSCs [100].